From: "Hiie Soeorg" <hiie.soeorg@ut.ee>
To: "Info - SOM" <info@sm.ee>
References: <DU0PR02MB86183DBA0098CCDA50A87B87F50A2@DU0PR02MB8618.eurprd02.prod.outlook.com>
In-Reply-To: <DU0PR02MB86183DBA0098CCDA50A87B87F50A2@DU0PR02MB8618.eurprd02.prod.outlook.com>
Subject: Gripi vastu vaktsineerimine Eestis
Date: Mon, 8 Jun 2026 08:52:18 +0300
Keywords: Mall
Message-ID: <DU0PR02MB86188059DD6D24A88CEE05B6F51C2@DU0PR02MB8618.eurprd02.prod.outlook.com>
MIME-Version: 1.0
Content-Type: multipart/alternative;
	boundary="----=_NextPart_000_0015_01DCF724.86582840"
Thread-Index: AQL5fY9l9AQLxcFB4tP4/4OyZ8IhcAF5nkfP
X-MS-Exchange-Organization-ExpirationStartTime: 08 Jun 2026 05:52:23.2258
 (UTC)
X-MS-Exchange-Organization-ExpirationStartTimeReason: OriginalSubmit
X-MS-Exchange-Organization-ExpirationInterval: 1:00:00:00.0000000
X-MS-Exchange-Organization-ExpirationIntervalReason: OriginalSubmit
X-MS-Exchange-Organization-Network-Message-Id: 44051f3d-aa77-45cf-bc50-08dec5221c94
X-EOPAttributedMessage: 0
X-EOPTenantAttributedMessage: 8fe098d2-428d-4bd4-9803-7195fe96f0e2:0
X-MS-Exchange-Organization-MessageDirectionality: Incoming
X-MS-PublicTrafficType: Email
X-MS-TrafficTypeDiagnostic: DU0PR02MB8618:EE_|AS2PR02MB9740:EE_|AMS0EPF000001AC:EE_|AS1PR02MB7941:EE_|DB9PR02MB7817:EE_
X-MS-Exchange-Organization-AuthSource: AMS0EPF000001AC.eurprd05.prod.outlook.com
X-MS-Exchange-Organization-AuthAs: Anonymous
X-MS-Office365-Filtering-Correlation-Id: 44051f3d-aa77-45cf-bc50-08dec5221c94
X-MS-Exchange-AtpMessageProperties: SA|SL
X-MS-Exchange-Organization-SCL: -1
X-Microsoft-Antispam: BCL:0;ARA:13230040|35042699022|31052699007|82310400026|18003699003|55112099003|5063699009|8096899003|11063799006|56012099006|19002099003|16102099003|22082099003;
X-Forefront-Antispam-Report: CIP:213.184.53.4;CTRY:EE;LANG:et;SCL:-1;SRV:;IPV:CAL;SFV:NSPM;H:mail1.rit.ee;PTR:mail1.rit.ee;CAT:NONE;SFS:(13230040)(35042699022)(31052699007)(82310400026)(18003699003)(55112099003)(5063699009)(8096899003)(11063799006)(56012099006)(19002099003)(16102099003)(22082099003);DIR:INB;
X-MS-Exchange-CrossTenant-OriginalArrivalTime: 08 Jun 2026 05:52:23.0071
 (UTC)
X-MS-Exchange-CrossTenant-Network-Message-Id: 44051f3d-aa77-45cf-bc50-08dec5221c94
X-MS-Exchange-CrossTenant-Id: 8fe098d2-428d-4bd4-9803-7195fe96f0e2
X-MS-Exchange-CrossTenant-AuthSource: AMS0EPF000001AC.eurprd05.prod.outlook.com
X-MS-Exchange-CrossTenant-AuthAs: Anonymous
X-MS-Exchange-CrossTenant-FromEntityHeader: Internet
X-MS-Exchange-Transport-CrossTenantHeadersStamped: AS1PR02MB7941
X-MS-Exchange-Transport-CrossTenantHeadersStamped: AS2PR02MB9740
X-MS-Exchange-Transport-EndToEndLatency: 00:00:04.0259168
X-MS-Exchange-Processed-By-BccFoldering: 15.21.0092.005
X-MS-Exchange-ExternalInOutlookResult: NotEnabled
X-Microsoft-Antispam-Mailbox-Delivery: ucf:0;jmr:0;auth:0;dest:I;ENG:(910005)(944506478)(944626604)(920097)(930201)(20251009189)(140003);
X-Microsoft-Antispam-Message-Info: =?us-ascii?Q?q9PgAI/XM/3wfsLifvVcb87ukpSMy4bGBM2G8AaMyMTaP0zv6502lSiQafjC?=
 =?us-ascii?Q?2X4gGo+Q6Ik+bUAPdVtvo6tTRl4o/EHyL0Z96gPFotwTy9epRFX4Fgqik8jT?=
 =?us-ascii?Q?V6LHbxyxqARa23HWja15SXpnefF/Ayw87nb8IrXZVzPmm91wc7SZAaX4o4AV?=
 =?us-ascii?Q?x9I0J8RFhSq7h7psb0tQkbRClle0mpPErNmfreNOumkeUW+bO9elhp2yaZIO?=
 =?us-ascii?Q?B1dH2RsrF8GDYVM6HHTW7WN61b4x+Abif/liEGPkY3TiJFT6aWwfkADysltx?=
 =?us-ascii?Q?2snjAHgjHH0GJao394+zFtAEXtE/1thRHqpQzxO3nyeQeMMQKo20o6bbYwvg?=
 =?us-ascii?Q?wgC4kb7l8XHE1aogpIIwrVUrzRHZY3bsG37JxTiLixClLECZrSs9Hdl9yf+3?=
 =?us-ascii?Q?cS0gIvD1ZxZuV29YjS05kVMckvJWQi+0JuoxwuXpxYFgkgtxaxVmgvtfo1Cf?=
 =?us-ascii?Q?ACuDnu3DLXEgQ7PK6Q2Z3vZoUvFtJveXIWzgoyw1kMqJn1B98gsBUO75yqB9?=
 =?us-ascii?Q?j4Lvwf/zPNyD+uVKILMFEii3Cf2nQlz2LDUfD7mlRyMG2nJH+gaalWvAJCb8?=
 =?us-ascii?Q?REaqWAc8RPE75C9xCX8Ni3AZI1rwsZokDDvu2OkZSFzFXzl2sJSJeMN50bxb?=
 =?us-ascii?Q?01RIRyHt64huAPUk5m7QhqByD+D5F2R+VIuRCP/ioEsnszbJISe80wlqxE7K?=
 =?us-ascii?Q?LCj1KoP2E0hYugzEcNuscpWjRCjAFFcfZllnOkVQW14nwCLTHMZ
	xmXjvl87W?=
 =?us-ascii?Q?8UekVBU5Ozb3wdbfcZp+TS3zoj+gr3CrAw8EoFSSuOqdF69779FNUn9WymOO?=
 =?us-ascii?Q?M5I3M9lDGdZwoKwoENliR/Y8XJH5T7k2awN/ReWyRneEgXBDMcAwIpwmOATM?=
 =?us-ascii?Q?T0JubarHba76u4bBa2Lr/VWGGb+eqGQkUNojdC6zB89avbEw/SmcxjdldX+n?=
 =?us-ascii?Q?TtyQYjWC92cc3SBHez7A5fA2uEgTWY7FSt9yzmXmbkHwr6b9WszDOBzcLcxU?=
 =?us-ascii?Q?XeACUADwBy2CGT25swl1kfckZJffThONm4bIuPJRidFh1hOTHb1ZdjwOdiOX?=
 =?us-ascii?Q?FozxYCc4gWNC8zpFUuLOW8TKY6IHjG61c/yK3jBtnJY+DaeORUYZyOsH7BvP?=
 =?us-ascii?Q?fRI62qS8g+hFUImGqiAySw7d8HLUPAdHRpLvZ1nIcMh9BMbbaJ1Eu+pLs9jY?=
 =?us-ascii?Q?u7/wT5GdJQ0L3NDIUC/RlwjzFlSns34J8Rj4HlJsIZ1p4q5k0qCgxgZbtQz2?=
 =?us-ascii?Q?Zq4kuFIZ6DXXT57sqz6Ig/rDYQvx9kGbpHi1UHefDiS8afATH8dX5+4zjBd8?=
 =?us-ascii?Q?SjlaoQNPcYRmjqZivUB4ozr2e1D3tK63+ktG3kmfUoA30fT0RDlrRh/mbY/q?=
 =?us-ascii?Q?yS4+P77up9E8nxJ8QaL0JFHcieni1uS7X5fZllWBxhIFhepb3kLiIY+nDnwb?=
 =?us-ascii?Q?bYQtpIzavFrfyHv+lC1SO7Ai2SBi1iieM4wzIwmG004OlAjfSQ5ZhVVvWUKV?=
 =?us-ascii?Q?YeJJ98rmevk+uJrT0yjQnoeaoTTf0UNo1D73N
	BDcO7oG9SxDjwhEA5YdJq1h?=
 =?us-ascii?Q?/y0hSlxrk0w6YYZTC1HQ50o/VMm/KjDGLrlvTa3yQdhZCso8o5aMp9zBrOgF?=
 =?us-ascii?Q?5WU9BBz96+BeA1+nCIlWrfMIaG9NhVDeOoq74YZDRM+XoUArwkcEkNn7YFMf?=
 =?us-ascii?Q?yd77xzegxOW0faV64Z8n6xvbf0bx3h4RT4Db2oEivaqDf9y5J4jLUgWB7460?=
 =?us-ascii?Q?hKj7QrxtPVcf00ccqCcoFtpfEIzhQDl5S1mNz5sehFdtK95xVya4gFRk0WUa?=
 =?us-ascii?Q?PAF5bFl9RVmNbxfzGAaImWTlg0JVrIMPm7/LmzfiKR6PmOS84yG7daztgdjB?=
 =?us-ascii?Q?cyO5R43a2Avphfw2t3y8kJuoU/NlRjlvyXrn4JjsaRUfkffOFQQU9zks5SOy?=
 =?us-ascii?Q?yKFZspU16RzYB7UvfLFFtBtLe3/Tw1solFALsHDdbU32/raj6QrJU6n0NiGy?=
 =?us-ascii?Q?72AqfutA3JbWhitIGvbGjR+R6N6FH35QKjTyg5oP1huDmG3Gk/7DStQfV/cD?=
 =?us-ascii?Q?KPUfDnlfTtiC/xq9WItDrtTQyrdX7NZAPBD9LvMhEfR0TReq4l6MaKqiv/mM?=
 =?us-ascii?Q?s4hVISW90ESk+/HqaL3J1iq3QbH+Iv/YGpQ2WbJkq1QN66uoVAa3mo0iCchT?=
 =?us-ascii?Q?2LpYlLlaGgtUGyrDhzPcExbpLGJhpQuCLgctgV3ehnXoQ+lyLL11WAmk39ij?=
 =?us-ascii?Q?ELD/n4bwFxIFKhp3J9cTw5d68xmD8Okls7wlBrXzhIOBZBOyNwG5ooj/Cz/G?=
 =?us-ascii?Q?JpTPCBBRVT3xTUV0Vp/sx85
	KKcSUFkynv/2KLOCSZ5lTSdz/B0XCEt2u/Fkb?=
 =?us-ascii?Q?LimzASqzy+gRqSqAlw+C7qM0APp+5fxkTScsBFJcDroxYTP/024QRGcDWmo1?=
 =?us-ascii?Q?RBys+g8lTVn7Hb31EYNTXNiKUjBMqRbXYK/p4SKoUQufjQwucYBBuxddMrtp?=
 =?us-ascii?Q?lK+xCVgGF+u+sXby+t0qM4ZEr3uIrz1sde43Tw/cC/qM28NbwIZQQYHc8hBX?=
 =?us-ascii?Q?RRZLbLzwRtM4LxYY1i2DD0pcWdgCJ1ZkzgKwUfJHr/s/Ze0pfGsuPamKrLMl?=
 =?us-ascii?Q?X5hfNE9609Eg+JA/3LhK/y8iypTNPWqev1sgdumV0QbwC7E082SUA8rtaPTo?=
 =?us-ascii?Q?YCADFgrtLXsXHfGhbtSgu7DXH3/y4Khjn5YOUCOdFP2G2i9ZkOdCC85cwe5f?=
 =?us-ascii?Q?ShWLYyIjeh5TyrBvJiYX8PSfOBpLM/odIFsYOo2NtgqV9u+u9MPjoSE15MXZ?=
 =?us-ascii?Q?JbSROGQ2N7hpl61Wpm9caVTicUfryhVO0D3nDNwYIlbjrWZ6PQnT3msyh613?=
 =?us-ascii?Q?CbsosDGlj8S5GAwkNqMX/+MssJ/mDH5mqzzmto6EGs1BuvHfWHAVVHAfe92o?=
 =?us-ascii?Q?Qzqx0aoPpnMV6ffTu6Go1Dam7tWPvPIkfy//BLGYPnVuFwKq/rqkBt+EsRMN?=
 =?us-ascii?Q?K3ccVBPP3nvHf8mxnNCJrzrqgCgdd1nB150yEBsh+17IsMDY1ARHPQ6qgBUB?=
 =?us-ascii?Q?NVNeBd/1g3K9goZAuxsHluEVVKwmGOuNJnEkIe3Nip2PK/gqy+oe6G5Qa4QH?=
 =?us-ascii?Q?SvtuI8R2Q
	KFX?=
Content-Language: et
x-ms-exchange-organization-originalclientipaddress: 213.184.53.4
x-ms-exchange-organization-originalserveripaddress: 10.167.16.152
received-spf: Pass (mail1.rit.ee: domain of  postmaster@DU2PR03CU002.outbound.protection.outlook.com  designates 52.101.65.107 as permitted sender) identity=helo;  client-ip=52.101.65.107; receiver=mail1.rit.ee;  envelope-from="hiie.soeorg@ut.ee";  x-sender="postmaster@DU2PR03CU002.outbound.protection.outlook.com";  x-conformance=spf_only; x-record-type="v=spf1";  x-record-text="v=spf1 ip4:40.92.0.0/15 ip4:40.107.0.0/16  ip4:52.100.0.0/15 ip4:52.102.0.0/16 ip4:52.103.0.0/17  ip4:104.47.0.0/17 ip6:2a01:111:f400::/48  ip6:2a01:111:f403::/49 ip6:2a01:111:f403:8000::/51  ip6:2a01:111:f403:c000::/51 ip6:2a01:111:f403:f000::/52 -all"
dkim-signature: v=1; a=rsa-sha256; c=relaxed/relaxed; d=ut.ee; s=selector1; h=From:Date:Subject:Message-ID:Content-Type:MIME-Version:X-MS-Exchange-SenderADCheck; bh=D3YjEdk42TyUQ3EUKXmFPCczF6Y+aErOu4M/yYHoomE=; b=CzfhAuUwq8DW+UggkZjcfrK/8UNh7dUQNxCQo2colR8cVgZ3BmTDFsj4WFgREmGgx7sgw2/daXVQWX2RS2nrsO+2RVo4zeyzOPHWPAUsJxG5I6AG4KSnLDMx1iOJwafEjBGt2951PWbwGsvqSSBze8rl3vNGhsL+lDLVrPKNlyQYD78Hgh7uXg/8Uoehibj3LSFhYRQFUIXAwHkTU9sSR614uEuZ9FobXjtAcL2jX2/FlgHLzJUR7arQNXV+Ttgtqg9xLFaDgHqAYabKCOQ4ZATOvFjSbe66mduBIBuANqEI8RPB/5dliY1vfZh1O6zUUbRoy6ZkCspGdwx0mD2GZA==
X-MS-Has-Attach: 
X-MS-TNEF-Correlator: 
x-ms-exchange-senderadcheck: 1
x-ms-exchange-antispam-relay: 0
X-Microsoft-Antispam-Untrusted: BCL:0;ARA:13230040|10070799003|19092799006|1800799024|376014|366016|786006|38070700021|18002099003|22082099003|56012099006|11063799006|8096899003;
X-Microsoft-Antispam-Message-Info-Original: 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
X-Forefront-Antispam-Report-Untrusted: CIP:255.255.255.255;CTRY:;LANG:et;SCL:1;SRV:;IPV:NLI;SFV:NSPM;H:DU0PR02MB8618.eurprd02.prod.outlook.com;PTR:;CAT:NONE;SFS:(13230040)(10070799003)(19092799006)(1800799024)(376014)(366016)(786006)(38070700021)(18002099003)(22082099003)(56012099006)(11063799006)(8096899003);DIR:OUT;SFP:1102;
X-MS-Exchange-AntiSpam-MessageData-Original-ChunkCount: 1
X-MS-Exchange-AntiSpam-MessageData-Original-0: =?iso-8859-15?Q?H8OkQyOKwJ9wiWAslDk2vDMT5adiNq0Ycsl33xKfiG5BY2T/7iC3573PK?=
 =?iso-8859-15?Q?EbZIGwQ8YNjwdgK2QshGQz0IRGaw/0EfzLlXWSr0HgaqDVmpjlIcGpDlB?=
 =?iso-8859-15?Q?WUsU1jUoccvGz7tsuXNbdorL5DRoTK97c2SQIprm2VWeZC4/MxZnLDS5x?=
 =?iso-8859-15?Q?P0yVhSMSfSQl0bEYjnA/Q3tR7U8AxVGYKuAt33+WVs/b/P0IXXaFpV9bq?=
 =?iso-8859-15?Q?hr215UJR38ILFvET+ZHnTN6qU1hDnnt+193eQH7KvOvD/w1/Sl+6IzxfH?=
 =?iso-8859-15?Q?0udZ2btcQ+u3aQfGeDIhIWrg5HPnfticJSm4cdixJB40vin4kfnqVERD1?=
 =?iso-8859-15?Q?5ExB7DgTKtiXm969YUgFUNQSdzRzECIMlN1Wr9xfD5voVgH8ADJdLsO7j?=
 =?iso-8859-15?Q?lapZ5W+fc/5ApJLBOxiJ25JIWj1BOc/E2LwXy57IUzp3qU41JLT8zsQO5?=
 =?iso-8859-15?Q?IzbSKtn7uPEpbEv2wWA+Wls06+sFxEcre7ULLxhkoz6W27Klg7E/mFyjm?=
 =?iso-8859-15?Q?zDW2WMHCx5km6uI0TSN1S7fuTyQuwAIcXgM1bRZT7FvgEuLxLOK7wpDj8?=
 =?iso-8859-15?Q?sGuJuti18LZDyzS8HjlCiFHwTG3or4vRl/9XOAOukDpEfWk1iDUd3IRoI?=
 =?iso-8859-15?Q?DP+SaOKKOs9emZ3F+axIK9unKnRZv8OjwSoU6riTKpRhKgCxti0cGlPL1?=
 =?iso-8859-15?Q?1y6oXqGWPmKPm35gSyqImGHm50UZOvMYX6ZMlHmoX1jBR8X6
	ujyt0JDio?=
 =?iso-8859-15?Q?RHcQUgOJgqScWYEiWQQHEPvRtVe8oTYE4+NMCx9fVRbRzNvvV8KMjX8Jd?=
 =?iso-8859-15?Q?gAwIXmoe5dtfxy4GgMeCfZQEbpQndiK278gP77YiT3/jZnCgq6FaEscVG?=
 =?iso-8859-15?Q?RCw/K7oDTp/kMtnaV5JfzRHUptfHdiHYpDGMd5EneO5M338ArpGq5oA30?=
 =?iso-8859-15?Q?i+MrYBde4pW5wyzf+ygxViKZL/X1HWRuNzVpxY51dfyQ/PTAnJPMq03Ri?=
 =?iso-8859-15?Q?jiAZFb0Udpi3HFW4KGhvgAxW0+6o96AgFH0ufFkFWvXDCrBv4hcd+bBJj?=
 =?iso-8859-15?Q?K87g1+dUuLHjc04oYWZNZpH4ZXHLElLRwtkbCK+uzROHMpD6nn5zBG02v?=
 =?iso-8859-15?Q?2KOhRc1mURu+95V4Bt3lZYTdwfFi0uWw8sUqGNxyOFrZul/CsFOHwdy9u?=
 =?iso-8859-15?Q?MyuLK1A+tVxezZBOucNGeLXV3q7FP43S1e7P2m1JQFWniXAkbDK1kSBFt?=
 =?iso-8859-15?Q?p8Mne4fDv1QO5aBbSi2Ut3OLXkPgZ7Z6FUrmsKaRKrTdRKmoFDw7OhUSz?=
 =?iso-8859-15?Q?AV16PA07LIGHLt8W4tGVoncT8IXrGu2MVWohCCo97YSW8BdKkOkGJ2uCJ?=
 =?iso-8859-15?Q?d6nEESlUsGLJUH5hGW1DdAHz+s/v28D8t5HoETGP7mSX75OB4Y/MI/y0L?=
 =?iso-8859-15?Q?ahYHQt0BxCEX3qGIxKgPF5V8GaE8PpINBaUOvTRM/jQpTj/vN8X9Mb8t4?=
 =?iso-8859-15?Q?yuI0613lIRaHySlS2mkStHBUzxxhtWfj3G
	2NCoDrukTQhuu64AwUMHClI?=
 =?iso-8859-15?Q?UhMiOE1jfpMTZIhXE6nCYak+OWD353rkXVNX6+IAS+ePJuMV4dxY30LBm?=
 =?iso-8859-15?Q?vWvQWcYsN3TlFZzLR7vRn4oxJNG+TvjXu5mRFqIiO8ktHp+SL0mPpil0L?=
 =?iso-8859-15?Q?cfUM/nNlPUxsQke5MBB/V4eMLFgN3p84Vc0QEwI6C+08ZBpbwwqKIZsOf?=
 =?iso-8859-15?Q?CemX725wTOyPYNkDaUGrGdy1KzABIaTyAkCsTi3ARVX3yGC/dTUFHGqlY?=
 =?iso-8859-15?Q?7LU0QJ/RN8TxTcV68u?=
X-MS-Exchange-Transport-CrossTenantHeadersStripped: AMS0EPF000001AC.eurprd05.prod.outlook.com
X-MS-Office365-Filtering-Correlation-Id-Prvs: 879afa1f-4830-420b-0d1a-08dec52219d4
acceptlanguage: et-EE, en-US
X-OlkEid: 00000000D07AAE8E23CDBE4CA04D01CCD82FCB7E070034AD76187591974DBF6C4F76951C873A01000200000000005797C783AAECB34FA6C879FF487E64D9000000000D5100000724FA966C79DC409E9D31D09AE1B23F
msip_labels: 
X-DisclaimerOO: 1

This is a multipart message in MIME format.

------=_NextPart_000_0015_01DCF724.86582840
Content-Type: text/plain;
	charset="iso-8859-15"
Content-Transfer-Encoding: 8bit


Tähelepanu! Tegemist on välisvõrgust saabunud kirjaga.
Tundmatu saatja korral palume linke ja faile mitte avada.

Tere!

Olen Tartu Ülikooli meditsiinilise mikrobioloogia teadur ning valmistan
ette terviseportaali andmetel põhinevat uuringut hooajalise gripivastase
vaktsineerimise hõlmatuse ja gripiga seotud raskete haigustulemuste kohta
Eestis 2012-2024.

Uuringu jaoks vajan informatsiooni, kuidas on Eestis alates 2012. aastast
muutunud riiklikult rahastatud gripivastane vaktsineerimine. Täpsemalt
sooviksin teada alates 2012. aastast:

1. Millised elanikkonnarühmad said hooajalise gripivaktsiini tasuta ehk
riiklikult rahastatuna? Kui esines muudatusi, millal jõustusid need
muudatused sihtrühmades?
2. Kas tasuta vaktsineerimise teenuse osutamise koht muutus ajas, näiteks
millal lisandus apteegis vaktsineerimise võimalus?
3. Kas aastatel oli ajutisi või kampaaniapõhiseid tasuta vaktsineerimise
võimalusi, mis ei pruugi immuniseerimiskavade versioonides kajastuda?

Oleksin väga tänulik ülevaate eest. Võimalusel palun ka viiteid
õigusaktidele vm dokumentidele.

Tänan!

Lugupidamisega
Hiie Soeorg


Hiie Soeorg

Meditsiinilise mikrobioloogia teadur

Mikrobioloogia osakond

Bio- ja siirdemeditsiini instituut

Meditsiiniteaduste valdkond

Tartu Ülikool

Ravila 19, 50411 Tartu

e-post:  <mailto:hiie.soeorg@ut.ee> hiie.soeorg@ut.ee




------=_NextPart_000_0015_01DCF724.86582840
Content-Type: text/html;
	charset="iso-8859-15"
Content-Transfer-Encoding: quoted-printable

<html><head>
<meta http-equiv=3D"Content-Type" content=3D"text/html; =
charset=3Diso-8859-15">
<style type=3D"text/css" style=3D"display:none;"> P =
{margin-top:0;margin-bottom:0;} </style>
</head>
<body dir=3D"ltr">
<table class=3D"MsoNormalTable" border=3D"0" cellspacing=3D"0" =
cellpadding=3D"0" align=3D"left" width=3D"100%" =
style=3D"width:100.0%;mso-cellspacing:0cm;mso-yfti-tbllook:1184; =
mso-table-lspace:2.25pt;mso-table-rspace:2.25pt;mso-table-anchor-vertical=
:paragraph;mso-table-anchor-horizontal:column;mso-table-left:left;mso-pad=
ding-alt:0cm 0cm 0cm 0cm">
<tbody>
<tr =
style=3D"mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes">
<td style=3D"background:#910A19;padding:5.25pt 1.5pt 5.25pt 1.5pt"></td>
<td width=3D"100%" =
style=3D"width:100.0%;background:#FDF2F4;padding:5.25pt 3.75pt 5.25pt =
11.25pt; word-wrap:break-word" cellpadding=3D"7px 5px 7px 15px" =
color=3D"#212121">
<div>
<p class=3D"MsoNormal" =
style=3D"mso-element:frame;mso-element-frame-hspace:2.25pt; =
mso-element-wrap:around;mso-element-anchor-vertical:paragraph;mso-element=
-anchor-horizontal: column;mso-height-rule:exactly">
<span style=3D"font-size:9.0pt;font-family: &quot;Segoe =
UI&quot;,sans-serif;mso-fareast-font-family:&quot;Times New =
Roman&quot;;color:#212121"><strong>T=E4helepanu!
</strong>Tegemist on v=E4lisv=F5rgust saabunud kirjaga.<br>
Tundmatu saatja korral palume linke ja faile mitte =
avada.<o:p></o:p></span></p>
</div>
</td>
</tr>
</tbody>
</table>
<div>
<div style=3D"direction: ltr; font-family: Aptos, Aptos_EmbeddedFont, =
Aptos_MSFontService, Calibri, Helvetica, sans-serif; font-size: 12pt; =
color: rgb(0, 0, 0);">
Tere!</div>
<div style=3D"direction: ltr; font-family: Aptos, Aptos_EmbeddedFont, =
Aptos_MSFontService, Calibri, Helvetica, sans-serif; font-size: 12pt; =
color: rgb(0, 0, 0);">
<br>
</div>
<div style=3D"direction: ltr; font-family: Aptos, Aptos_EmbeddedFont, =
Aptos_MSFontService, Calibri, Helvetica, sans-serif; font-size: 12pt; =
color: rgb(0, 0, 0);">
Olen Tartu =DClikooli meditsiinilise mikrobioloogia teadur ning =
valmistan ette terviseportaali andmetel p=F5hinevat uuringut hooajalise =
gripivastase vaktsineerimise h=F5lmatuse ja gripiga seotud raskete =
haigustulemuste kohta Eestis 2012-2024.</div>
<div style=3D"direction: ltr; font-family: Aptos, Aptos_EmbeddedFont, =
Aptos_MSFontService, Calibri, Helvetica, sans-serif; font-size: 12pt; =
color: rgb(0, 0, 0);">
<br>
</div>
<div style=3D"direction: ltr; font-family: Aptos, Aptos_EmbeddedFont, =
Aptos_MSFontService, Calibri, Helvetica, sans-serif; font-size: 12pt; =
color: rgb(0, 0, 0);">
Uuringu jaoks vajan informatsiooni, kuidas on Eestis alates 2012. =
aastast muutunud riiklikult rahastatud gripivastane vaktsineerimine. =
T=E4psemalt sooviksin teada alates 2012. aastast:</div>
<div style=3D"direction: ltr; font-family: Aptos, Aptos_EmbeddedFont, =
Aptos_MSFontService, Calibri, Helvetica, sans-serif; font-size: 12pt; =
color: rgb(0, 0, 0);">
<br>
</div>
<div style=3D"direction: ltr; font-family: Aptos, Aptos_EmbeddedFont, =
Aptos_MSFontService, Calibri, Helvetica, sans-serif; font-size: 12pt; =
color: rgb(0, 0, 0);">
1. Millised elanikkonnar=FChmad said hooajalise gripivaktsiini tasuta =
ehk riiklikult rahastatuna? Kui esines muudatusi, millal j=F5ustusid =
need muudatused sihtr=FChmades?</div>
<div style=3D"direction: ltr; font-family: Aptos, Aptos_EmbeddedFont, =
Aptos_MSFontService, Calibri, Helvetica, sans-serif; font-size: 12pt; =
color: rgb(0, 0, 0);">
2. Kas tasuta vaktsineerimise teenuse osutamise koht muutus ajas, =
n=E4iteks millal lisandus apteegis vaktsineerimise v=F5imalus?</div>
<div style=3D"direction: ltr; font-family: Aptos, Aptos_EmbeddedFont, =
Aptos_MSFontService, Calibri, Helvetica, sans-serif; font-size: 12pt; =
color: rgb(0, 0, 0);">
3. Kas aastatel oli ajutisi v=F5i kampaaniap=F5hiseid tasuta =
vaktsineerimise v=F5imalusi, mis ei pruugi immuniseerimiskavade =
versioonides kajastuda?</div>
<div style=3D"direction: ltr; font-family: Aptos, Aptos_EmbeddedFont, =
Aptos_MSFontService, Calibri, Helvetica, sans-serif; font-size: 12pt; =
color: rgb(0, 0, 0);">
<br>
</div>
<div style=3D"direction: ltr; font-family: Aptos, Aptos_EmbeddedFont, =
Aptos_MSFontService, Calibri, Helvetica, sans-serif; font-size: 12pt; =
color: rgb(0, 0, 0);">
Oleksin v=E4ga t=E4nulik =FClevaate eest. V=F5imalusel palun ka viiteid =
=F5igusaktidele vm dokumentidele.</div>
<div style=3D"direction: ltr; font-family: Aptos, Aptos_EmbeddedFont, =
Aptos_MSFontService, Calibri, Helvetica, sans-serif; font-size: 12pt; =
color: rgb(0, 0, 0);">
<br>
</div>
<div style=3D"direction: ltr; font-family: Aptos, Aptos_EmbeddedFont, =
Aptos_MSFontService, Calibri, Helvetica, sans-serif; font-size: 12pt; =
color: rgb(0, 0, 0);">
T=E4nan!</div>
<div style=3D"direction: ltr; font-family: Aptos, Aptos_EmbeddedFont, =
Aptos_MSFontService, Calibri, Helvetica, sans-serif; font-size: 12pt; =
color: rgb(0, 0, 0);">
<br>
</div>
<div style=3D"direction: ltr; font-family: Aptos, Aptos_EmbeddedFont, =
Aptos_MSFontService, Calibri, Helvetica, sans-serif; font-size: 12pt; =
color: rgb(0, 0, 0);">
Lugupidamisega</div>
<div style=3D"direction: ltr; font-family: Aptos, Aptos_EmbeddedFont, =
Aptos_MSFontService, Calibri, Helvetica, sans-serif; font-size: 12pt; =
color: rgb(0, 0, 0);">
Hiie Soeorg</div>
<div id=3D"x_Signature">
<div style=3D"direction: ltr; font-family: Aptos, Aptos_EmbeddedFont, =
Aptos_MSFontService, Calibri, Helvetica, sans-serif; font-size: 12pt; =
color: rgb(0, 0, 0);">
<br>
</div>
<p style=3D"direction: ltr; margin: 0cm 0cm 0.0001pt; font-family: =
Calibri, sans-serif; font-size: 11pt;">
Hiie Soeorg</p>
<div style=3D"direction: ltr; margin: 0cm 0cm 0.0001pt; font-family: =
Calibri, sans-serif; font-size: 11pt; color: rgb(66, 66, 66);">
<span style=3D"background-color: rgba(0, 0, 0, 0);">Meditsiinilise =
mikrobioloogia teadur</span></div>
<p style=3D"direction: ltr; margin: 0cm 0cm 0.0001pt; font-family: =
Calibri, sans-serif; font-size: 11pt;">
Mikrobioloogia osakond</p>
<p style=3D"direction: ltr; margin: 0cm 0cm 0.0001pt; font-family: =
Calibri, sans-serif; font-size: 11pt;">
Bio- ja siirdemeditsiini instituut</p>
<p style=3D"direction: ltr; margin: 0cm 0cm 0.0001pt; font-family: =
Calibri, sans-serif; font-size: 11pt;">
Meditsiiniteaduste valdkond</p>
<p style=3D"direction: ltr; margin: 0cm 0cm 0.0001pt; font-family: =
Calibri, sans-serif; font-size: 11pt;">
Tartu =DClikool</p>
<p style=3D"direction: ltr; margin: 0cm 0cm 0.0001pt; font-family: =
Calibri, sans-serif; font-size: 11pt;">
Ravila 19, 50411 Tartu</p>
<p style=3D"direction: ltr; margin: 0cm 0cm 0.0001pt; font-family: =
Calibri, sans-serif; font-size: 11pt;">
e-post: <span style=3D"color: rgb(5, 99, 193);"><a =
href=3D"mailto:hiie.soeorg@ut.ee" =
id=3D"OWAb92dc452-e4e0-288a-bd9c-54f93763aacb" class=3D"x_OWAAutoLink" =
style=3D"color: rgb(5, 99, 193); margin-top: 0px; margin-bottom: =
0px;"><u>hiie.soeorg@ut.ee</u></a></span></p>
<p style=3D"direction: ltr; margin: 0cm 0cm 0.0001pt; font-family: =
Calibri, sans-serif; font-size: 11pt;">
&nbsp;</p>
</div>
</div>
</body>
</html>

------=_NextPart_000_0015_01DCF724.86582840--